NPDI-AIlkaw
|
Green tea (Camellia sinensis)
|
Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes
|
Inhibition of CYP3A by (-)-Epigallocatechin Gallate in HIM (Ki Determination)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
(-)-epigallocatechin gallate
|
NPDI-FMvj7w
|
Green tea (Camellia sinensis)
|
Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes
|
Inhibition of CYP3A by (-)-Epigallocatechin Gallate in HIM (IC50 Determination)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
(-)-epigallocatechin gallate
|
NPDI-LZlNyQ
|
Green tea (Camellia sinensis)
|
Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes
|
Inhibition of CYP3A by (-)-Epigallocatechin Gallate in HLM (Ki Determination)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
(-)-epigallocatechin gallate
|
NPDI-6x_uKQ
|
Green tea (Camellia sinensis)
|
Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes
|
Inhibition of CYP3A by (-)-Epigallocatechin Gallate in HLM (IC50 Determination)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
(-)-epigallocatechin gallate
|
NPDI-Cuu5WA
|
Green tea (Camellia sinensis)
|
Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450
|
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
epigallocatechin gallate
|
NPDI-JGDRVA
|
Green tea (Camellia sinensis)
|
Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450
|
Percent inhibition of CYP3A4 by epicatechin gallate
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
epicatechin gallate
|
NPDI-j7Vnlw
|
Goldenseal (Hydrastis canadensis)
|
Repeated administration of berberine inhibits cytochromes P450 in humans
|
CYP3A4 Experiment
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
midazolam
|
|
berberine
|
NPDI-Aw3yIw
|
Goldenseal (Hydrastis canadensis)
|
Supplementation With Goldenseal (Hydrastis canadensis), but not Kava Kava (Piper methysticum), Inhibits Human CYP3A Activity In Vivo
|
CYP3A4 Experiment - MDZ probe
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
midazolam
|
|
goldenseal root extract
|
NPDI-Bi2fGw
|
Goldenseal (Hydrastis canadensis)
|
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4 phenotypes
|
CYP3A4 Experiment
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
midazolam
|
|
goldenseal root extract
|
NPDI-hYXlNQ
|
Goldenseal (Hydrastis canadensis)
|
An ex vivo approach to botanical-drug interactions: A proof of concept study
|
3A4/5 Inhibition by Goldenseal
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
goldenseal root extract
|
NPDI-PaRJNQ
|
Goldenseal (Hydrastis canadensis)
|
An ex vivo approach to botanical-drug interactions: A proof of concept study
|
3A4/5 Inhibition by Berberine (PB)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
berberine
|
NPDI-6AJ-fg
|
Goldenseal (Hydrastis canadensis)
|
An ex vivo approach to botanical-drug interactions: A proof of concept study
|
3A4/5 Inhibition by Hydrastine (PB)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
hydrastine
|
NPDI-KGE4lw
|
Goldenseal (Hydrastis canadensis)
|
An ex vivo approach to botanical-drug interactions: A proof of concept study
|
3A4/5 Inhibition by Berberine (Plasma)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
berberine
|
NPDI-gAs6gw
|
Goldenseal (Hydrastis canadensis)
|
An ex vivo approach to botanical-drug interactions: A proof of concept study
|
3A4/5 Inhibition by Hydrastine (Plasma)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
hydrastine
|
NPDI-_UID1w
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
3A4 Inhibition by Hydrastine (MDZ)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
hydrastine
|
NPDI-cnkDpg
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
3A4 Inhibition by Ethanolic GS Extract (MDZ)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
ethanolic goldenseal extract
|
NPDI-Z0x9xQ
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
3A4 Inhibition by Aq GS Extract (MDZ)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
aqueous goldenseal extract
|
NPDI-ov597g
|
Kratom (Mitragyna speciosa)
|
Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations
|
Screening of mitragynine as inhibitors of CYP3A activity in HLM
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
mitragynine
|
NPDI-7-Gg-g
|
Kratom (Mitragyna speciosa)
|
Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations
|
Screening of kratom extracts as inhibitors of CYP3A activity in HLM
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
methanolic extract of kratom
|
NPDI-vr5BAA
|
Kratom (Mitragyna speciosa)
|
Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations
|
Screening of mitragynine as inhibitors CYP3A activity in HIM
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
mitragynine
|
NPDI-QbMPuw
|
Kratom (Mitragyna speciosa)
|
Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations
|
Screening of kratom extracts as inhibitors CYP3A activity in HIM
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
mitragynine
|
NPDI-515DHw
|
Kratom (Mitragyna speciosa)
|
Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations
|
Inhibition kinetics of CYP3A activity by mitragynine in HLM
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
mitragynine
|
NPDI-Tr3Eyg
|
Kratom (Mitragyna speciosa)
|
Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations
|
Inhibition kinetics of CYP3A activity by mitragynine in HIM
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
mitragynine
|
NPDI-4_UdSg
|
Kratom (Mitragyna speciosa)
|
Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations
|
IC50 shift determination for mitragynine towards CYP3A activity in HLM with NADPH
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
mitragynine
|
NPDI-EjMg0g
|
Kratom (Mitragyna speciosa)
|
Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations
|
IC50 shift determination for mitragynine towards CYP3A activity in HLM without NADPH
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
mitragynine
|
NPDI-A66pwQ
|
Kratom (Mitragyna speciosa)
|
Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations
|
IC50 shift determination for mitragynine towards CYP3A activity in HIM with NADPH
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
mitragynine
|
NPDI-o8WmjA
|
Kratom (Mitragyna speciosa)
|
Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations
|
IC50 shift determination for mitragynine towards CYP3A activity in HIM without NADPH
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
mitragynine
|
NPDI-7z5LQg
|
Licorice (Glycyrrhiza glabra)
|
Cytochrome P450 inhibition by licorice species Glycyrrhiza glabra L. and fourteen licorice constituents
|
Negligible inhibition of CYP3A4 by G. glabra Licorice extract
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
ethanolic extract of licorice g. glabra
|
NPDI-aX49Ng
|
Licorice (Glycyrrhiza uralensis)
|
Cytochrome P450 inhibition by licorice species Glycyrrhiza uralensis and fourteen licorice constituents
|
Negligible inhibition of CYP3A4 by G. uralensis Licorice extract
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
ethanolic extract of licorice g. uralensis
|
NPDI-pHgnHQ
|
Licorice (Glycyrrhiza inflata)
|
Cytochrome P450 inhibition by licorice species Glycyrrhiza inflata and fourteen licorice constituents
|
Inhibition of CYP3A4 by G. inflata Licorice extract
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
ethanolic extract of licorice g. inflata
|
NPDI-CAfs7A
|
licochalcone a
|
Inhibition of CYP enzymes by licochalcone a
|
Inhibition of CYP3A4 by Licochalcone A
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
licochalcone a
|
NPDI-kew9FQ
|
Kratom (Mitragyna speciosa)
|
Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
|
Control Positive Inhibition for CYP3A4/5
|
In Vitro Enzyme Inhibition
(Control experiment)
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
ketoconazole
|
NPDI-c_gPeA
|
Kratom (Mitragyna speciosa)
|
Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
|
Inhibition of Mitragynine for CYP3A4/5
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
mitragynine
|
NPDI-QQeDSQ
|
Kratom (Mitragyna speciosa)
|
Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
|
Inhibition of Speciogynine for CYP3A4/5
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
speciogynine
|
NPDI-TTv3Iw
|
Kratom (Mitragyna speciosa)
|
Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
|
Inhibition of Speciociliatine for CYP3A4/5
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
speciociliatine
|
NPDI-7PU97Q
|
Kratom (Mitragyna speciosa)
|
Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
|
Inhibition of Corynantheidine for CYP3A4/5
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
corynantheidine
|
NPDI-olaGPQ
|
Kratom (Mitragyna speciosa)
|
Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
|
Weak Inhibition of 7-hydroxymitragynine for CYP3A4/5
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
7-hydroxymitragynine
|
NPDI-WakYGw
|
Kratom (Mitragyna speciosa)
|
Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
|
Inhibition of Paynantheine for CYP3A4/5
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
paynantheine
|
NPDI-DboNmw
|
Goldenseal (Hydrastis canadensis)
|
A clinical study of transporter-mediated goldenseal drug interactions
|
clinical goldenseal - midazolam experiment
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
midazolam
|
|
goldenseal root extract
|
NPDI-FsyoWg
|
Gou Teng (Uncaria rhynchophylla)
|
Identification of PXR activators from Uncaria rhynchophylla (Gou Teng)
|
Gou Teng 1/2500 Extracts on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
gou teng extract
|
NPDI-hg991g
|
Cat's-claw (Uncaria tomentosa)
|
Identification of PXR activators from Uncaria tomentosa (Cat’s Claw)
|
Cat's Claw 1/5000 Extracts on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
cat's claw extract
|
NPDI-jUInZg
|
Gou Teng (Uncaria rhynchophylla)
|
Identification of PXR activators from Uncaria rhynchophylla (Gou Teng)
|
Isocorynoxeine on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
isocorynoxeine
|
NPDI-scab3g
|
Kratom (Mitragyna speciosa)
|
Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom
|
kratom tea - midazolam interaction clinical NPDI study
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
midazolam
|
|
water extract of kratom
|
NPDI-cyF5-w
|
Gou Teng (Uncaria rhynchophylla)
|
Identification of PXR activators from Uncaria rhynchophylla (Gou Teng)
|
Gou Teng 1/500 Extracts on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
gou teng extract
|
NPDI-lVB-wQ
|
Gou Teng (Uncaria rhynchophylla)
|
Identification of PXR activators from Uncaria rhynchophylla (Gou Teng)
|
Gou Teng 1/250 Extracts on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
gou teng extract
|
NPDI-irr70Q
|
Gou Teng (Uncaria rhynchophylla)
|
Identification of PXR activators from Uncaria rhynchophylla (Gou Teng)
|
Gou Teng 1/100 Extracts on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
gou teng extract
|
NPDI-sfIKSQ
|
Gou Teng (Uncaria rhynchophylla)
|
Identification of PXR activators from Uncaria rhynchophylla (Gou Teng)
|
Gou Teng 1/50 Extracts on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
gou teng extract
|
NPDI-VZwgtA
|
Gou Teng (Uncaria rhynchophylla)
|
Identification of PXR activators from Uncaria rhynchophylla (Gou Teng)
|
Rhynchophylline on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
rhynchophylline
|
NPDI-3oSxuQ
|
Gou Teng (Uncaria rhynchophylla)
|
Identification of PXR activators from Uncaria rhynchophylla (Gou Teng)
|
Isorhynchophylline on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
isorhynchophylline
|
NPDI-D-IVFw
|
Gou Teng (Uncaria rhynchophylla)
|
Identification of PXR activators from Uncaria rhynchophylla (Gou Teng)
|
Corynoxeine on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
corynoxeine
|
NPDI-NxBuuA
|
Cat's-claw (Uncaria tomentosa)
|
Identification of PXR activators from Uncaria tomentosa (Cat’s Claw)
|
Cat's Claw 1/2500 Extracts on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
cat's claw extract
|
NPDI-h8CxDA
|
Cat's-claw (Uncaria tomentosa)
|
Identification of PXR activators from Uncaria tomentosa (Cat’s Claw)
|
Cat's Claw 1/1000 Extracts on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
cat's claw extract
|
NPDI-nRt2ng
|
Cat's-claw (Uncaria tomentosa)
|
Identification of PXR activators from Uncaria tomentosa (Cat’s Claw)
|
Cat's Claw 1/500 Extracts on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
cat's claw extract
|
NPDI-McqRuA
|
Cat's-claw (Uncaria tomentosa)
|
Identification of PXR activators from Uncaria tomentosa (Cat’s Claw)
|
Mitraphylline on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
mitraphylline
|
NPDI-bb32sA
|
Cat's-claw (Uncaria tomentosa)
|
Identification of PXR activators from Uncaria tomentosa (Cat’s Claw)
|
Pteropodine on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
pteropodine
|
NPDI-SZr2oA
|
Cat's-claw (Uncaria tomentosa)
|
Identification of PXR activators from Uncaria tomentosa (Cat’s Claw)
|
Isopteropodine on CYP3A4 Activity
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
midazolam
|
1'-hydroxymidazolam
|
isopteropodine
|
NPDI-d2rDLg
|
Cannabis (Cannabis sativa)
|
Drug Approval Package: Epidiolex (Cannabidiol)
|
CBD Effect on Midazolam
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
|
midazolam
|
|
cannabidiol
|